Search

The American Society for Microbiology (ASM) and the Infectious Diseases Society of America (IDSA) are hosting the Interdisciplinary Meeting on Antimicrobial Resistance and Innovation, taking place on January 28-30, 2026. The conference aims

Precisio Biotix Therapeutics and the Mayo Clinic have announced their first patient dosed with ClyO staph lysin for multidrug-resistant prosthetic joint infection treatment.

Iddo Weiner (BiomX Ltd) and colleagues published a new paper on their nebulized phage cocktail for cystic fibrosis, showing BX004-A met safety endpoints and demonstrated potential reduction in P. aeruginosa sputum burden in first-in-human t

Claudia Campobasso (University of Pisa) and colleagues published a new paper on serum lipid inhibition of phage activity, showing human serum lipids impair Staphylococcus aureus phage infectivity in a strain-specific manner by coating bacte

Jennifer Sequoia (Stanford University) and colleagues published a new paper on phage DNA detection in umbilical cord blood, showing that phage DNA is present in human fetal circulation at birth, providing evidence of prenatal exposure to ph

Jiucheng Ma (Zhangjiagang Hospital, Soochow University) and colleagues published a new paper on novel phage therapy for MDR Pseudomonas aeruginosa, showing vB_PaeP_PZH3 effectively reduced bacterial loads and promoted wound healing in mouse

A phage display platform screens large libraries of chemically cyclized peptides carrying an affinity tag and a turn-on fluorescent reporter, so cleavage can be quantified in every selection round, to find selective substrates for a proteas

Why don't we have phage therapy yet? We want to understand why. Come join the fun by tuning into the Podovirus podcast! 🎙️ Most recent episode: Dr. Marisa Azad, infectious disease physician at The Ottawa Hospital, shares her experience le

You’re invited to submit an abstract to the inaugural Conference on Bacteriophages: Biology, Dynamics, and Therapeutics, chaired by Graham Hatfull (University of Pittsburgh) and Robert (Chip) Schooley (UCSD). Topics range from phage struct

Tolka AI Therapeutics has announced expanded access to patient-tailored phage therapy for M. abscessus infections. They're screening patients at five institutions for compassionate use where standard antibiotics have failed.

Dr. Stephen Vaughan (University of Calgary) successfully treated 76-year-old Boyd English's decade-long antibiotic-resistant hip infection using phage therapy. This is the first PJI phage treatment in Western Canada.

Masako Shimamura (Nationwide Children's Hospital and the Ohio State University) and colleagues published a new paper on dual β-lactam therapy for macrolide-resistant M. abscessus, showing successful treatment of two pediatric cases using mu

Kai Wang (Huazhong Agricultural University, China) and colleagues published a new paper on novel trimethoprim resistance genes in phage-plasmids, showing identification of two functional dfrA genes (dfrA50 and dfrA51) that confer trimethopr

Jialin Xiang (Wuhan University) and colleagues published a new paper on type IV pili-mediated archaeal virus mutualism, showing that co-resident temperate viruses SNJ1 and SNJ2 establish tripartite mutualistic interactions with their haloar

Michael Doud (University of California, San Diego) and colleagues published a new paper on AI applications in phage therapy, showing how AI can improve phage-host matching, discover novel phage genes, and guide development of synthetic ther

Jung and colleagues analysed the genomic, proteomic and functional characteristics of four bacteriophages (STP-1 to STP-4) targeting Salmonella Typhimurium, finding lysis-related genes (holin, endolysin, RZ-like spanins) and no genes linked

A first-in-human, double-blind, placebo-controlled phase 1b/2a trial evaluated nebulized three-phage cocktail BX004-A in nine adults with cystic fibrosis and chronic Pseudomonas aeruginosa infection. The trial met its primary safety and tol

In mouse models of acute Pseudomonas aeruginosa pneumonia, depleting alveolar macrophages shortened the survival of adult male mice without raising lung bacterial load, yet lung P. aeruginosa levels were significantly lower in macrophage-de

The Global Clinical Phage Rounds (GCPR) is an ongoing forum for discussing phage therapy cases and advances among clinicians and scientists. The organizers (Greg German, Gina Suh, Jon Iredell and colleagues) are excited to announce a speci

You’re invited to submit an abstract to the inaugural Conference on Bacteriophages: Biology, Dynamics, and Therapeutics, chaired by Graham Hatfull (University of Pittsburgh) and Robert (Chip) Schooley (UCSD). Topics range from phage struct